/Lists

Biotech Late Stage Investors & VC Firms

360 firms in this list, with a median first check of $1M. 82 of them lead rounds. Generated from verified public data and updated continuously.

Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
15 people
Sofina
BrusselsSeed–Late Stage$100M – $300M
57 people
Granite Asia
SingaporeSeed–Late Stage$5M – $25M
35 people
Nextech Invest
ZurichSeed–Late Stage$648K – $3.2M
43 people
Catalio Capital Management, LP
New YorkSeed–Late Stage
37 people
Meusinvest (Noshaq)
LiegeSeed–Late Stage
67 people
South Park Commons
San FranciscoPre-Seed–Late Stage$1M – $10M
13 people
Hercules Capital, Inc.
San MateoSeries C–Late Stage
51 people
OUP (Osage University Partners)
Bala CynwydPre-Seed–Late Stage$1M – $20M
21 people
Bain Capital Life Sciences
BostonSeries B–Late Stage
31 people
Nazca
Mexico CityPre-Seed–Late Stage
32 people
Pfizer Venture Investments
Seed–Late Stage$5M – $20M
16 people
Astorg
ParisGrowth–Late Stage
51 people
Forbion
NaardenPre-Seed–Late Stage
25 people
Eurazeo
ParisSeed–Late Stage
35 people
Vida Ventures
Los AngelesPre-Seed–Late Stage
44 people
S32
Palo AltoSeries A–Late Stage
30 people
ATEL Ventures
San FranciscoSeed–Late Stage
15 people
The Column Group
San FranciscoPre-Seed–Late Stage$30M
38 people
AME Cloud Ventures
Palo AltoSeed–Late Stage$1M – $10M
11 people
Ireland Strategic Investment Fund
DublinSeed–Late Stage
Vensana Capital
MinneapolisSeries A–Late Stage
43 people
aMoon
Ra'ananaSeed–Late Stage
33 people
Blue Venture Funds
ChicagoSeed–Late Stage$1M – $20M
28 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.